Anavex Life Sciences
AVXL
#7501
Rank
HK$3.28 B
Marketcap
HK$36.72
Share price
-4.28%
Change (1 day)
-49.18%
Change (1 year)

EPS for Anavex Life Sciences (AVXL)

EPS in 2025 (TTM): -HK$4.21

According to Anavex Life Sciences 's latest financial reports the company's current EPS (TTM) is -HK$4.22. a decrease over its 2024 EPS that were of -HK$4.06.

EPS history for Anavex Life Sciences from 2004 to 2025

Annual EPS

Year EPS Change
2025-HK$4.223.85%
2024-HK$4.06-13.33%
2023-HK$4.69-3.23%
2022-HK$4.8414.81%
2021-HK$4.2220%
2020-HK$3.52-16.67%
2019-HK$4.2238.46%
2018-HK$3.0518.18%
2017-HK$2.58-21.43%
2016-HK$3.28-35.38%
2015-HK$5.08-36.27%
2014-HK$7.97112.5%
2013-HK$3.75-58.62%
2012-HK$9.06-0%
2011-HK$9.06-29.27%
2010-HK$12.8151.85%
2009-HK$8.44-0%
2008-HK$8.44237.5%
2007-HK$2.50
2006N/A-100%
2005-HK$0.31499.97%
2004-HK$0.05209

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Ligand Pharmaceuticals
LGND
HK$18.67-542.59%๐Ÿ‡บ๐Ÿ‡ธ USA
Corcept Therapeutics
CORT
HK$7.81-285.19%๐Ÿ‡บ๐Ÿ‡ธ USA
Palatin Technologies
PTN
-HK$233.60 5,437.04%๐Ÿ‡บ๐Ÿ‡ธ USA
BioCryst Pharmaceuticals
BCRX
-HK$0.39-90.74%๐Ÿ‡บ๐Ÿ‡ธ USA